While GAMP 4 claimed to be "risk-based," in practice, it was . Here is the primary criticism:
The requirement to trace every user requirement through design, coding, and testing to ensure 100% coverage became a non-negotiable best practice. This drastically reduced missing requirements in validated systems. While GAMP 4 claimed to be "risk-based," in practice, it was
Released in December 2001 by the ISPE (International Society for Pharmaceutical Engineering), GAMP 4 was a landmark document that expanded the scope of validation beyond just manufacturing to include laboratory, clinical, and distribution systems. Evolution and Historical Significance " in practice